Premium
Collaborative research and development on mifepristone in China to reduce unwanted pregnancies and recourse to abortion
Author(s) -
Duncan G.W.
Publication year - 1999
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/s0020-7292(99)00149-6
Subject(s) - mifepristone , medicine , emergency contraception , abortion , china , private sector , foundation (evidence) , gynecology , family planning , obstetrics , medical emergency , economic growth , pregnancy , population , research methodology , environmental health , law , political science , genetics , economics , biology
A program proposed and executed by The Concept Foundation and funded by the Rockefeller Foundation demonstrates the feasibility of using private/public‐sector collaboration for making mifepristone widely available. The application of mifepristone to emergency, luteal phase and menstrual induction contraception is being assessed in clinical research programs conducted in accordance with international standards for good clinical research. Opportunities for introduction of mifepristone in developing countries are being pursued using mifepristone produced in China in accordance with international standards of good manufacturing practice.